EOG Resources has caught a bid this week, rising nearly 4% to $134.54, but the analyst community spent the past week cutting price targets even as they kept positive ratings — a gap worth watching as Q3 earnings approach.
The most active Street story this week is a split in analyst conviction. Jefferies bucked the trend, raising its target from $170 to $175 while holding Buy. UBS moved the other way, trimming from $168 to $158 while staying constructive. Morgan Stanley and Truist both lowered targets — Truist's cut was the sharpest, from $149 to $134, landing almost exactly at the current price and reflecting an unchanged Hold. Taken together, the direction of travel is cautious: the consensus mean target sits at $158, implying about 17% upside from here, but the gravitational pull of recent revisions is downward. Bulls point to EOG's capital returns discipline — the company returned 100% of free cash flow to shareholders in FY25 — and the strategic logic of the $5.6 billion Encino acquisition adding Utica Shale scale ahead of rising LNG and data center demand. Bears counter with the commodity price risk that makes that cash flow projection fragile, and lingering uncertainty about well productivity trends.
Positioning data does nothing to complicate that picture — if anything, it confirms the lack of conviction on the short side. Short interest is drifting lower, now at 3.3% of free float, down about 10% from the late-June peak of roughly 3.8% when around 2.4 million shares were unwound in a single session. The lending market remains wide open: availability is running at 3,710%, meaning there are more than 37 shares available to borrow for every one currently lent out. Cost to borrow has picked up sharply in percentage terms — more than doubling on the week to 0.62% — but in absolute terms that remains trivially cheap. The ORTEX short score holds near 38.4, well within the range it has occupied for the past two weeks, consistent with a short-side story that has stabilised rather than rebuilt. There is no squeeze setup here, and no sign of renewed short conviction.
Options traders are similarly relaxed. The put/call ratio has drifted down to 0.54, about 0.8 standard deviations below its 20-day average of 0.60. That's near the 52-week low of 0.52, meaning call activity is dominant — investors are reaching for upside exposure rather than buying protection. That shift is meaningful in context: just a month ago the PCR was running closer to 0.70, reflecting considerably more defensive positioning. The move lower in the ratio has tracked the stock's partial recovery from its May lows and suggests the options market is broadly aligned with the stock's bounce this week.
The sector lifted broadly Tuesday, with close peers COP, APA, and MTDR all gaining between 3% and 5% on the day, suggesting a crude price or macro catalyst rather than anything EOG-specific. On the week, MTDR leads the peer group at nearly 5%, while CHRD and DVN lag slightly. EOG's 3.7% weekly gain is in line with the pack. Factor scores add some texture: forward EPS growth ranks in the 93rd percentile of the universe, and the dividend score sits at 78 — both constructive. But near-term EPS momentum has slipped to the 25th percentile on a 30-day basis, which tracks with the wave of target cuts and reflects softened commodity expectations in sell-side models.
Q3 results are scheduled for August 5. The two most recent earnings prints both produced sharp next-day declines — roughly 7% after the May 6 report and 3% after the May 20 event. With the stock back near where Truist's Hold target lands and the Street broadly trimming rather than upgrading, whether EOG can close that gap to the consensus mean by August will depend heavily on crude price direction between now and then.
See the live data behind this article on ORTEX.
Open EOG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
